tiprankstipranks
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

Abivax Announces Share and Voting Rights Update
Company AnnouncementsAbivax Announces Share and Voting Rights Update
14d ago
Abivax SA: Promising Clinical Developments and Positive Outlook Justify Buy Rating
PremiumRatings
Abivax SA: Promising Clinical Developments and Positive Outlook Justify Buy Rating
14d ago
ABVX
Abivax Files Key Financial Documents with Regulatory Authorities
PremiumCompany Announcements
Abivax Files Key Financial Documents with Regulatory Authorities
15d ago
Promising Prospects for Abivax: Buy Rating Backed by Clinical Progress and Financial Strength
PremiumRatings
Promising Prospects for Abivax: Buy Rating Backed by Clinical Progress and Financial Strength
16d ago
ABVX
Abivax SA’s Obefazimod: A Promising Blockbuster in Ulcerative Colitis Treatment
PremiumRatings
Abivax SA’s Obefazimod: A Promising Blockbuster in Ulcerative Colitis Treatment
16d ago
ABVX
Positive Outlook for Abivax: Buy Rating Supported by Promising Phase 3 Trials and Strong Financial Position
PremiumRatingsPositive Outlook for Abivax: Buy Rating Supported by Promising Phase 3 Trials and Strong Financial Position
17d ago
ABVX
Abivax SA Reports 2024 Financial Results and Advances Phase 3 Trials
Premium
Company Announcements
Abivax SA Reports 2024 Financial Results and Advances Phase 3 Trials
17d ago
0RA9 Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
0RA9 Earnings this Week: How Will it Perform?
19d ago
Abivax assumed with an Equal Weight at Morgan Stanley
PremiumThe Fly
Abivax assumed with an Equal Weight at Morgan Stanley
21d ago
ABVX
Buy Rating for Abivax SA Driven by Promising Obefazimod Data and Market Potential
PremiumRatings
Buy Rating for Abivax SA Driven by Promising Obefazimod Data and Market Potential
22d ago
ABVX
Abivax’s Obefazimod: A Promising New Treatment for Ulcerative Colitis with Phase 3 Data Anticipated in 2025
PremiumRatings
Abivax’s Obefazimod: A Promising New Treatment for Ulcerative Colitis with Phase 3 Data Anticipated in 2025
23d ago
ABVX
Buy Rating for Abivax: Promising Potential of Obefazimod in Ulcerative Colitis Treatment
PremiumRatings
Buy Rating for Abivax: Promising Potential of Obefazimod in Ulcerative Colitis Treatment
24d ago
ABVX
Abivax Announces Share and Voting Rights Update
PremiumCompany AnnouncementsAbivax Announces Share and Voting Rights Update
1M ago
Abivax to Host Webcast on Ulcerative Colitis Treatments and Phase 3 Trial Insights
Premium
Company Announcements
Abivax to Host Webcast on Ulcerative Colitis Treatments and Phase 3 Trial Insights
2M ago
Abivax management to meet with Piper Sandler
Premium
The Fly
Abivax management to meet with Piper Sandler
2M ago
ABVX
Abivax Releases 2025 Financial Communication Schedule
PremiumCompany Announcements
Abivax Releases 2025 Financial Communication Schedule
2M ago
Abivax Discloses Share Capital and Voting Rights Information
PremiumCompany Announcements
Abivax Discloses Share Capital and Voting Rights Information
2M ago
Abivax Presents Key Findings on Obefazimod at ECCO 2025
PremiumCompany Announcements
Abivax Presents Key Findings on Obefazimod at ECCO 2025
3M ago
Abivax Achieves Significant Progress in Phase 3 Ulcerative Colitis Trial
PremiumCompany Announcements
Abivax Achieves Significant Progress in Phase 3 Ulcerative Colitis Trial
3M ago
Abivax Announces Board Change as Key Director Resigns
PremiumCompany AnnouncementsAbivax Announces Board Change as Key Director Resigns
4M ago
Abivax initiated with an Outperform at JMP Securities
Premium
The Fly
Abivax initiated with an Outperform at JMP Securities
4M ago
ABVX
Abivax SA Ends Liquidity Contract, Reports Cash Balance
Premium
Company Announcements
Abivax SA Ends Liquidity Contract, Reports Cash Balance
6M ago

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >